A phase II trial of single oral FGF inhibitor, AZD4547, as...

Lung Cancer 2020 / 02 Vol. 140

A phase II trial of single oral FGF inhibitor, AZD4547, as second or third line therapy in malignant pleural mesothelioma

Lam, Wei-Sen, Creaney, Jenette, Chen, Fred K., Chin, Wee Loong, Muruganandan, Sanjeevan, Arunachalam, Sukanya, Attia, Mary S., Read, Catherine, Murray, Kevin, Millward, Michael, Spiro, Jon, Chakera, A
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
140
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2019.12.018
Date:
February, 2020
File:
PDF, 492 KB
2020
Conversion to is in progress
Conversion to is failed